All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
06/02/22	4	Statement of changes in beneficial ownership of securities Documents EX-24	3
06/02/22	4	Statement of changes in beneficial ownership of securities Documents EX-24	3
06/02/22	4	Statement of changes in beneficial ownership of securities Documents EX-24	3
06/02/22	4	Statement of changes in beneficial ownership of securities Documents EX-24	3
06/02/22	4	Statement of changes in beneficial ownership of securities Documents EX-24	3
05/16/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	110
04/21/22	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	3
04/21/22	DEF 14A	Definitive proxy statements	43
04/11/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	3
04/04/22	4	Statement of changes in beneficial ownership of securities	2